What is NDC 87333-001?

87333-001 is the product NDC for Cardiolite, Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate 1 mg/mL injection, powder, lyophilized, for solution, listed with the FDA by SHINE SPECT USA, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Cardiolite (Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate).

What is the active ingredient?

Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate.

SHINE SPECT USA, LLC, NDC labeler code 87333. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cardiolite?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cardiolite NDC 87333-001 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)87333-001Labeler and product segments. Claims need a package NDC.

Product NDC at billing width87333-0001Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
87333-001-20	8733300012087333000120	20 VIAL in 1 BOX (87333-001-20) / 5 mL in 1 VIALMarketed from Sep 10, 2026
87333-001-55	8733300015587333000155	5 VIAL in 1 BOX (87333-001-55) / 5 mL in 1 VIALMarketed from Sep 10, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cardiolite
Generic name (nonproprietary): tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate
Active ingredients: Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate — 1 mg/mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: SHINE SPECT USA, LLCNDC labeler code 87333
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 019785
Marketing start: Sep 10, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 87333-001_258f6ed0-be7d-4c94-b737-fd822eb58c6cSPL ID 258f6ed0-be7d-4c94-b737-fd822eb58c6cSPL set ID 773b6729-2a74-49e7-9215-ca70da3b854cUNII N6OU7HJ70P

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N487333000120 followed by a unit qualifier and the quantity

Package 87333-0001-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 10, 2026.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE CARDIOLITE® is a myocardial perfusion agent indicated for: detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects) evaluating myocardial function and developing information for use in patient management decisions Myocardial Imaging: CARDIOLITE ® Kit for the Preparation of Technetium Tc99m Sestamibi for Injection, is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. C…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 87333-001

What is NDC 87333-001?: 87333-001 is the product NDC for Cardiolite, Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate 1 mg/mL injection, powder, lyophilized, for solution, listed with the FDA by SHINE SPECT USA, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Cardiolite (Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate).
What is the active ingredient?: Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate.
Who is the labeler?: SHINE SPECT USA, LLC, NDC labeler code 87333. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cardiolite?: 1 other product NDC are listed under this name. See all Cardiolite NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Cardiolite NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Cardiolitetetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate	Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate 1 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Lantheus Medical Imaging, Inc.	11994-001	11994-0001-2011994-0001-55

Other NDCs under NDA 019785

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 019785
Product	Strength	Form · route	Labeler	Product NDC
Cardiolitetetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate	Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate 1 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Lantheus Medical Imaging, Inc.	11994-001
Kit for the Preparation of Technetium Tc99m Sestamibitetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate	Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate 1 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Lantheus Medical Imaging, Inc.	11994-003